Antiplatelet agents and anaesthesia

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 7, Issue 5, 2007, Pages 157-161

  Smart, Simon ^a   Aragola, S ^a   Hutton, P ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34648823428     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkm030     Document Type: Article

References (13)

1. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: The relationships among dose, effectiveness, and side effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 234S-64S
2. Merritt JC, Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 2004; 17: 21-7
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002; 324: 71-86
4. Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 2004; 43: 963-81
5. Spahn DR, Howell SJ, Delabays A, Chassot PG. Coronary stents and perioperative anti-platelet regimen: Dilemma of bleeding and stent thrombosis. Br J Anaesth 2006; 96: 675-7
6. Zimarino M, Renda G, De Caterina R. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents. Drugs 2005; 65: 725-32
7. Harrison P. Platelet function analysis. Blood Rev 2005; 19: 111-23
8. Hobson AR, Agarwala RA, Swallow RA, Dawkins KD, Curzen NP Thromboelastography: Current clinical applications and its potential role in interventional cardiology. Platelets 2006; 17(8): 509-518
9. Michos ED, Ardehali R, Blumenthal RS, Lange RA, Ardehali H. Aspirin and clopidogrel resistance. Mayo Clin Proc 2006; 8: 518-26
10. Collett JP, Montalescot G, Blanchet B, Tanguy ML, Golmard JL, Choussat R, Beygui F, Payot L, Vignolles N, Metzger JP, Thomas D. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-2367
11. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257: 399-414
12. Horlocker T, Wedel DJ, Berzon H et al. Regional anesthesia in the anticoagulated patient: Defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28: 172-97
13. Lecompte T, Hardy J-F. Antiplatelet agents and perioperative bleeding. Can J Anesth 2006; 53: S103-12